Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.00
Ask:
7.50
Spread: 1.50 (25.00%)
Market Cap: £15.95m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

Pre-Close Trading Update

28 Apr 2026 07:00

RNS Number : 1040C
Symphony Environmental Tech. PLC
28 April 2026
 

 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

28 April 2026

 

Symphony Environmental Technologies plc

("Symphony", the "Company" or the "Group")

FY-2025 pre-close trading update and

 

Strong start to FY-2026 - first half profitability

 

Symphony Environmental Technologies plc ("Symphony" or the "Group"); global specialists in technologies that make plastic and rubber products "smarter, safer and sustainable", is pleased to provide the following pre-close trading update for the year ended 31 December 2025 ("FY-2025") and notice of FY-2025 results, together with a trading update for the current year to date.

FY2025 trading update (subject to audit)

Further to the Company's announcement on 17 December 2025, the Board now expects that, as a result of management‑driven strategic change in its Middle East operations, Group revenue for FY-2025 will be higher than previously guided, at approximately £5.7 million, with an adjusted loss before interest, tax, depreciation and amortisation ("adjusted LBITDA") broadly comparable to that incurred in the prior year, at approximately £0.9 million.

Importantly, and as further set out below, sales momentum has not just continued but accelerated during the first four months of FY-2026, running at more than 10 per cent. ahead of the same period last year. Furthermore, margins are also improving due to operational leverage as well as the positive impact of strategic initiatives taken during FY-2025, in particular in the Middle East.

In addition to the above adjusted LBITDA, the following one-off costs were incurred during FY-2025 as well as certain asset provisions will be made to the FY-2025 results:

· Strategic costs of £500,000 primarily in relation to the Middle East but also of certain future corporate initiatives;

· Impairment provision of £468,000 against development costs for the Group's antimicrobial products due to extended South American customer trials and commercial evaluation; and

· Other investment provisions of £107,000.

 

 

The net loss including provisions and strategic costs for FY-2025 is expected to be £2.5 million (FY-2024: £1.3 million).

The Board expects to announce its preliminary results for FY-2025 during the latter half of May.

Outlook

The Board remains focused on margin quality, disciplined cost control and the commercialisation of higher‑value technologies, rather than short‑term volume growth.

That said, it is particularly pleasing that trading in the first four months of 2026 has improved materially. The Group delivered a positive EBITDA in Q1-2026, compared with a loss in the corresponding prior‑year and based on current order patterns, expects to deliver a net profit for H1-2026.

Revenues are currently tracking more than 10 per cent ahead of the same period last year. Confirmed orders have been received across all principal markets, particularly Central America. While the timing of shipments remains subject to customer scheduling and customary operational factors, the Board is encouraged by the visibility and quality of the pipeline now in place, which underpins its confidence in the Group's earnings trajectory.

The Group continues to monitor the evolving geopolitical situation in the Middle East, which to date has not had a material adverse effect on operations.

Enquiries:

Symphony Environmental Technologies Plc

Michael Laurier, CEO

Tel: +44 (0) 20 8207 5900

Ian Bristow, CFO

www.symphonyenvironmental.com

Zeus (Nominated Adviser and Broker)

David Foreman, Emma Burn (Investment Banking)

Tel: +44 (0) 203 829 5000

NOTES TO EDITORS

 

 

About Symphony Environmental

 

 

Symphony's d2w masterbatch technology is added to polyethylene (PE) and polypropylene (PP) products at the manufacturing stage at little or no extra cost, and ensures that if they get into the environment at the end of their useful life they will not create microplastics and lie or float around for decades. https://www.symphonyenvironmental.com/technologies/biodegradable-plastic/ Instead they will safely biodegrade, leaving no microplastics or toxicity.

 

If they get collected during their programmed life they can be recycled with ordinary PE and PP without separation See https://www.biodeg.org/subjects-of-interest/recycling-2/

 

Symphony also supplies a range of plastic technologies under its d2p (designed to protect) brand www.d2p.net to provide protection against insects, viruses, bacteria, fungi, rodents, odours, and fire. 

 

It has also introduced a new product under its NbR brand https://www.symphonyenvironmental.com/natural-biodegradable-resin/ to reduce the amount of fossil-derived material in plastic products.

 

Symphony has a diverse and growing customer-base and has established itself as an international business with over 70 distributors around the world. Products made with Symphony's plastic technologies are now available in nearly 100 countries and in many different product applications. Symphony itself is certified according to ISO9001 and ISO14001.

 

Symphony participates in the Committee work of the British Standards Institute (BSI), the American Standards Organisation (ASTM), the European Standards Organisation (CEN), and the International Standards Organisation (ISO).

 

Further information on the Group can be found at www.symphonyenvironmental.com and twitter @SymphonyEnv

 

See also Symphony on Instagram and Linkedin.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVDSAIDFIR
Date   Source Headline
24th Jun 201111:29 amRNSResult of Annual General Meeting
24th Jun 201110:00 amRNSAGM Statement
23rd Jun 20117:00 amRNSd2w Update
22nd Jun 201111:48 amRNSNotification of Major Interest in Shares
1st Jun 20117:00 amRNSNotice of AGM
20th May 20117:00 amRNSExercise of Options and Issue of Equity
16th May 20117:00 amRNSIssue of Equity and Directors Dealings
27th Apr 20114:28 pmRNSHolding(s) in Company
21st Apr 20117:00 amRNSUS Distribution Agreement commences
11th Apr 20117:00 amRNSExercise of Options
5th Apr 20117:00 amRNSFinal Results
31st Mar 20117:00 amRNSChange of Adviser
28th Feb 20117:00 amRNSTotal Voting Rights
23rd Feb 20117:00 amRNSUSA Distribution Agreement and major PR campaign
9th Feb 20113:45 pmRNSExercise of Options and Issue of Equity
31st Jan 20113:30 pmRNSExercise of Options and Issue of Equity
14th Jan 20111:45 pmRNSHolding(s) in Company
11th Jan 20113:00 pmRNSHolding(s) in Company
1st Dec 20101:15 pmRNSHolding(s) in Company
29th Oct 20108:50 amRNSTotal Voting Rights
12th Oct 20102:00 pmRNSExercise of warrants
9th Sep 201012:45 pmRNSDirector/PDMR Shareholding
8th Sep 20103:30 pmRNSGrant of share options
6th Sep 20107:00 amRNSHalf Yearly Report
3rd Sep 201012:45 pmRNSExercise of warrants
6th Aug 201012:20 pmRNSInterim Results date and new technology contract
30th Jun 20103:50 pmRNSCompletion of reorganisation
21st Jun 201010:50 amRNSDirector/PDMR Shareholding
14th Jun 20107:00 amRNSDirector's dealings
28th May 20102:40 pmRNSTotal Voting Rights
28th May 201010:40 amRNSResult of AGM
17th May 201012:00 pmRNSDirectorate Change
11th May 20105:20 pmRNSIssue of Equity
5th May 20107:00 amRNSLeading Hotel Group to Use d2w Technology
29th Apr 20107:00 amRNSNotice of AGM
1st Apr 201012:26 pmRNSShare Options
30th Mar 201010:30 amRNSDirector/PDMR Shareholding
30th Mar 20107:00 amRNSFinal Results
26th Mar 201012:50 pmRNSChange of Registered Office
8th Mar 20108:00 amRNSNotice of Results
25th Jan 201011:30 amRNSShare Options
7th Jan 20107:00 amRNSBNY Mellon Level 1 ADR Programme
16th Dec 20097:00 amRNSDistribution Agreement
20th Nov 200912:00 pmRNSSupply Agreement with Superfos
30th Oct 20093:02 pmRNSTotal Voting Rights
2nd Oct 20092:33 pmRNSHolding(s) in Company
25th Sep 200912:23 pmRNSIssue of Equity
10th Sep 20097:00 amRNSInterim Results
14th Aug 20097:00 amRNSChange of Name of Nominated Adviser and Broker
5th Aug 20091:24 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.